dx.doi.org/10.1016/j.annonc.2020.09.007, hdl.handle.net/1765/132299
Annals of Oncology

van de Garde, E.M., van Bedaf, L.R., Hurkmans, D.P., & van den Heuvel, M.M. (2020). Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?. Annals of Oncology, 31(12), 1779–1780. doi:10.1016/j.annonc.2020.09.007